Charts, layoffs, insights and news for ZOLL Medical Corporation are members-only.Sign in →
New hirings vs layoffs · monthly
Δ = new hirings − layoffs
Hiring detail
Workforce composition · live
Hiring by region · country × title bucket
Layoffs
Strategic insights
Recent news
Date
Type
Headline
January 8, 2026
news
ZOLL Strengthens Growth Trajectory for Asahi Kasei’s Healthcare Sector with U.S. Launch of the Next-Generation LifeVest® WCD and Rollout of the Most Comfortable LifeVest Garment Ever, Reinforcing Position as Leader in WCD Category
ZOLL, an Asahi Kasei company, launched the next-generation LifeVest® wearable cardioverter defibrillator (WCD) in the U.S. and rolled out a more comfortable garment. This strategic move reinforces ZOLL's leadership in the WCD category, driven by continuous innovation and clinical evidence. The advancements contribute to Asahi Kasei's goal of achieving ¥55.0 billion in operating income for its Critical Care business by fiscal 2027, highlighting ZOLL's crucial role in its parent company's healthcare sector growth.
February 4, 2026
news
ZOLL Medical Appoints Eric Knudsen as New CEO
ZOLL Medical appointed Eric Knudsen as its new CEO, effective April 1, 2026, succeeding Jon Rennert, who will become Executive Chairman. Knudsen's extensive experience in medtech, particularly in business development and corporate strategy, and his leadership of ZOLL Itamar, are expected to drive continued growth and innovation in critical care solutions. This leadership change signifies a strategic move to leverage Knudsen's expertise for future expansion and market leadership.
February 10, 2026
news
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval
ZOLL's new Zenix monitor/defibrillator received EU MDR approval, marking a significant product launch for 2026. This device aims to enhance patient care and automate workflows in EMS and hospital settings with its intuitive design and advanced features like Real BVM Help® and Real CPR Help®. This approval and launch strengthen ZOLL's market position in professional monitors/defibrillators and demonstrate its commitment to innovation and regulatory compliance.
2026-06-18
product
Zoll receives FDA warning letter over quality concerns
2026-06-17
product
Zoll faces FDA warning letter related to quality, reporting processes
2026-06-17
product
FDA Issues Warning Letter to Zoll Medical for Manufacturing Violations Involving Life-Saving Devices
2026-05-28
product
ZOLL® Expands "Anything Can Happen. Anyone Can Help."tm to Strengthen Cardiac Emergency Readiness Across Youth Sports Nationwide
2026-05-27
product
ZOLL® Expands “Anything Can Happen. Anyone Can Help.”™ to Strengthen Cardiac Emergency Readiness Across Youth Sports Nationwide